Preliminary study of nanonized lamotrigine containing products for nasal powder formulation
Péter Gieszinger, Ildikó Csóka, Edina Pallagi, Gábor Katona, Orsolya Jójárt-Laczkovich, Piroska Szabó-Révész, Rita Ambrus Faculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Szeged, Hungary Abstract: The nasal delivery of drugs offers a great alt...
Saved in:
Main Authors: | Gieszinger P (Author), Csóka I (Author), Pallagi E (Author), Katona G (Author), Jójárt-Laczkovich O (Author), Szabó-Révész P (Author), Ambrus R (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2017-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of a microparticle-based dry powder inhalation formulation of ciprofloxacin hydrochloride applying the quality by design approach
by: Karimi K, et al.
Published: (2016) -
The Development of an In Vitro Horizontal Diffusion Cell to Monitor Nasal Powder Penetration Inline
by: Péter Gieszinger, et al.
Published: (2021) -
Formulation and In Vitro and In Silico Characterization of "Nano-in-Micro" Dry Powder Inhalers Containing Meloxicam
by: Petra Party, et al.
Published: (2021) -
The effect of ethanol on the habit and in vitro aerodynamic results of dry powder inhalation formulations containing ciprofloxacin hydrochloride
by: Edit Benke, et al.
Published: (2021) -
Development of an Innovative, Carrier-Based Dry Powder Inhalation Formulation Containing Spray-Dried Meloxicam Potassium to Improve the In Vitro and In Silico Aerodynamic Properties
by: Edit Benke, et al.
Published: (2020)